Keefe, Bruyette & Woods Has Lowered Expectations for Globe Life (NYSE:GL) Stock Price

Globe Life (NYSE:GL) had its target price reduced by equities research analysts at Keefe, Bruyette & Woods from $192.00 to $190.00 in a research report issued to clients and investors on Friday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Keefe, Bruyette & Woods’ target price suggests a potential upside of 9.42% from the company’s current price.

Other research analysts also recently issued research reports about the stock. Morgan Stanley upped their price target on shares of Globe Life from $181.00 to $208.00 and gave the stock an “overweight” rating in a research report on Monday, July 6th. Weiss Ratings cut shares of Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research report on Monday, July 20th. Piper Sandler boosted their target price on shares of Globe Life from $175.00 to $200.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 15th. Truist Financial boosted their target price on shares of Globe Life from $180.00 to $185.00 and gave the stock a “buy” rating in a research note on Friday, April 24th. Finally, JPMorgan Chase & Co. upped their target price on shares of Globe Life from $181.00 to $201.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 21st. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $187.40.

Globe Life Trading Up 1.5%

Shares of GL opened at $173.64 on Friday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.07 and a current ratio of 0.07. The company has a market cap of $13.48 billion, a price-to-earnings ratio of 11.53 and a beta of 0.47. The stock has a fifty day moving average price of $169.07 and a two-hundred day moving average price of $152.91. Globe Life has a 52-week low of $127.85 and a 52-week high of $191.55.

Globe Life (NYSE:GL) last announced its earnings results on Wednesday, July 22nd. The company reported $3.61 EPS for the quarter, missing the consensus estimate of $3.67 by ($0.06). The business had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.59 billion. Globe Life had a return on equity of 20.73% and a net margin of 19.58%.Globe Life’s revenue for the quarter was up 8.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $3.05 EPS. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Analysts predict that Globe Life will post 15.7 EPS for the current fiscal year.

Insider Transactions at Globe Life

In related news, CFO Thomas Peter Kalmbach sold 15,637 shares of the firm’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $153.65, for a total value of $2,402,625.05. Following the transaction, the chief financial officer owned 45,335 shares in the company, valued at $6,965,722.75. This trade represents a 25.65% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Frank M. Svoboda sold 20,000 shares of the firm’s stock in a transaction dated Friday, May 22nd. The shares were sold at an average price of $156.68, for a total value of $3,133,600.00. Following the completion of the transaction, the chief executive officer owned 54,020 shares in the company, valued at approximately $8,463,853.60. This represents a 27.02% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 90,187 shares of company stock worth $14,299,874. 2.11% of the stock is owned by insiders.

Institutional Investors Weigh In On Globe Life

Several institutional investors have recently modified their holdings of GL. CYBER HORNET ETFs LLC acquired a new position in Globe Life in the second quarter valued at approximately $28,000. Hilton Head Capital Partners LLC bought a new position in Globe Life in the fourth quarter valued at approximately $30,000. MUFG Securities EMEA plc acquired a new stake in Globe Life during the 2nd quarter worth $31,000. Torren Management LLC acquired a new stake in Globe Life during the 4th quarter worth $37,000. Finally, AdvisorNet Financial Inc raised its position in shares of Globe Life by 41.1% during the 1st quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock valued at $44,000 after acquiring an additional 92 shares during the last quarter. Institutional investors and hedge funds own 81.61% of the company’s stock.

Key Globe Life News

Here are the key news stories impacting Globe Life this week:

• Positive Sentiment: Keefe, Bruyette & Woods trimmed its price target only modestly to $190 from $192 and kept an outperform rating, implying roughly 9% upside from recent levels. Benzinga article
• Positive Sentiment: TD Cowen also reiterated a bullish view, forecasting strong price appreciation for Globe Life (GL). American Banking News article
• Positive Sentiment: Management raised its 2026 net operating EPS guidance to $15.55-$15.95 and lifted share repurchases to $670 million-$700 million, signaling confidence in future earnings and capital returns. Seeking Alpha article
• Neutral Sentiment: Globe Life’s Q2 revenue came in roughly in line with expectations, and underwriting income remained strong, showing the core business is still performing acceptably despite some headwinds. Reuters article
• Negative Sentiment: Q2 earnings of $3.61 per share missed the consensus estimate of $3.67, and several reports pointed to softer sales and rising expenses as reasons for investor concern. MSN article

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.